Patents by Inventor Elizabeth M. Long

Elizabeth M. Long has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified toll-like receptor 2 (TLR2) ligands as inhibitors of neutrophil recruitment
    Patent number: 9422335
    Abstract: The present invention provides modified TLR2 ligands useful for modulating inflammatory responses. In particular, the ligands comprise (a) a fatty acid di- or tri-linoleate and (b) a GM1-binding peptide. The linoleate provides the anti-inflammatory function, while the GM1-binding peptide facilitates endocytosis.
    Type: Grant
    Filed: August 30, 2012
    Date of Patent: August 23, 2016
    Assignee: UTI Limited Partnership
    Inventors: Elizabeth M. Long, Stephen M. Robbins, Paul Kubes, Ela Kolaczkowska
  • MODIFIED TOLL-LIKE RECEPTOR 2 (TLR2) LIGANDS AS INHIBITORS OF NEUTROPHIL RECRUITMENT
    Publication number: 20150065414
    Abstract: The present invention provides modified TLR2 ligands useful for modulating inflammatory responses. In particular, the ligands comprise (a) a fatty acid di- or tri-linoleate and (b) a GM1-binding peptide. The linoleate provides the anti-inflammtory function, while the GM1-binding peptide facilitates endocytosis.
    Type: Application
    Filed: August 30, 2012
    Publication date: March 5, 2015
    Applicant: UTI LIMITED PARTNERSHIP
    Inventors: Elizabeth M. Long, Stephen M. Robbins, Paul Kubes, Ela Kolaczkowska